Stellate Ganglion Block to Reduce Hot Flushes

NCT03756272 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2020-03-11

No results posted yet for this study

Summary

To assess the short-term efficacy of stellate ganglion block on hot flush reduction versus sham procedure

Conditions

  • Hot Flash
  • Stellate Ganglion Block
  • Postmenopausal
  • Hot Flushes

Interventions

PROCEDURE

Bupivacaine block

stellate ganglion bupivacaine injection

PROCEDURE

Placebo ganglion block

stellate ganglion sodium chloride injection

Sponsors & Collaborators

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • Jan Willem Kallewaard, MD · Rijnstate Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-04-28
Completion
2019-02-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03756272 on ClinicalTrials.gov